Molecular diagnostics maker Exact Sciences Corp. submitted data from the DeeP-C clinical trial June 7 for its Cologuard stool colorectal screening test, completing the company’s modular PMA application, and paving the way to request Medicare coverage through the FDA-CMS parallel review process.
The DeeP-C trial
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?